Exhibit 99.2





                          CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                           AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Annual Report of K-V Pharmaceutical Company (the
"Company") on Form 10-K for the fiscal year ended March 31, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Gerald R. Mitchell, Vice President, Treasurer and Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

    (1)  The Report fully complies with the  requirements of section 13(a)
         or 15(d) of the Securities  Exchange Act of 1934; and

    (2)  The information contained in the Report fairly presents,
         in all material respects, the financial condition and
         results of operations of the Company.









Date:  June 27, 2003                       /s/ Gerald R. Mitchell
                          -----------------------------------------------------
                                             Gerald R. Mitchell
                          Vice President, Treasurer and Chief Financial Officer
                               (Principal Financial and Accounting Officer)